en · de · es · fr · pt
semaglutide-notes.peptides4962.com › Blog › Semaglutide Structure And Receptor Mechanism — Field Notes

Semaglutide Structure And Receptor Mechanism — Field Notes

By Editorial Desk · published 2025-09-16 · last reviewed 2025-11-07 · Blog

DPP-4 resistance raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

This page was last updated on 2025-11-07 and is reviewed periodically as new material appears.

Semaglutide Structure and Receptor Mechanism

Receptor activation follows the canonical Gs pathway: binding increases intracellular cyclic AMP, which promotes protein kinase A activity. In pancreatic beta cells this amplifies glucose-dependent insulin release, so secretion rises when blood glucose is high and changes little when it is low. The same signalling suppresses glucagon release from alpha cells and slows gastric emptying. Receptors in the hypothalamus and brainstem are thought to contribute to reduced appetite and lower energy intake. Which of these effects dominates clinical outcomes remains an area of active study.

Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released by intestinal L cells after food intake. The natural hormone acts on pancreatic and central receptors but is degraded within minutes by dipeptidyl peptidase-4 and other peptidases. Semaglutide belongs to the class of long-acting GLP-1 receptor agonists, a group distinguished by structural changes that slow breakdown and extend circulation time. Its development followed earlier short-acting analogues and reflects a general strategy in peptide drug design: preserve receptor activity while blocking proteolytic clearance.

Mechanism and Pharmacological Class

The semaglutide sequence is a 31-residue analogue of human GLP-1, altered at three positions relative to the parent hormone. Aminoisobutyric acid replaces alanine at position 8, arginine replaces lysine at position 34, and a lipophilic diacid is attached to lysine 26 through a short linker. These features are reported consistently in the structural literature. The position 8 substitution blocks recognition by dipeptidyl peptidase-4, while the attached chain drives strong, reversible association with a carrier protein in blood.

Receptor activation raises intracellular cyclic AMP through Gs coupling, which promotes glucose-dependent insulin release and suppresses glucagon secretion when blood glucose is elevated. Effects outside the pancreas include slower gastric emptying and altered appetite signalling in the hypothalamus and hindbrain. The relative contribution of each tissue to overall metabolic outcomes remains an area of active investigation. Central mechanisms in particular are inferred mainly from animal models and indirect human measures rather than direct observation.

Serum protein binding dominates the pharmacokinetic profile. The attached chain associates strongly with albumin, shielding the peptide from enzymatic attack and slowing filtration by the kidney. This interaction extends the circulation half-life to roughly one week in humans, which supports weekly administration intervals. An oral version pairs the peptide with an absorption enhancer that transiently alters gastric epithelium, permitting limited uptake; bioavailability by that route is substantially lower than by injection.

Semaglutide at a glance

PropertyValueNotes
Molecular formulaC187H291N45O59free base, without counter-ion
Molecular weightAbout 4114 Dapeptide backbone plus attached lipid chain
Plasma half-lifeAbout 165 hourssupports once-weekly dosing in humans
Plasma protein bindingGreater than 99 percentattributed mainly to serum albumin
Receptor targetGLP-1 receptorGs-coupled, raises intracellular cyclic AMP

结构特征与受体作用机制

Semaglutide 是一种经结构修饰的胰高血糖素样肽-1 类似物,其主链与内源性 GLP-1(7-36) 约有百分之九十四的序列一致性。第 8 位丙氨酸被 α-氨基异丁酸取代,使二肽基肽酶-4 无法识别原有切割位点。第 34 位赖氨酸换为精氨酸,进一步降低酶解速率。第 26 位赖氨酸经间隔基连接一条含十八个碳的二酸脂肪链,该侧链赋予分子与血浆白蛋白结合的能力。

该分子作为 GLP-1 受体的选择性激动剂发挥作用,受体属于 B 类 G 蛋白偶联受体家族,激活后经 Gs 通路提升细胞内环腺苷酸水平。在胰腺 β 细胞,信号促进葡萄糖依赖性的胰岛素释放,血糖偏低时该作用明显减弱。在胰岛 α 细胞,胰高血糖素分泌受到抑制。中枢神经系统与胃肠道同样存在受体表达,相应信号参与食欲调节以及胃排空速率的降低。

皮下注射后吸收相对缓慢,绝对生物利用度约为百分之八十九,血药浓度峰值通常出现在给药后一到三天。与白蛋白结合使清除减慢,终末半衰期约为一百六十五小时,接近一周。连续给药约四到五周后达到稳态暴露水平。表观分布容积约为每千克零点二五升,血浆蛋白结合率超过百分之九十九。代谢以蛋白水解切割和脂肪二酸侧链的 β-氧化为主,相关产物主要经尿液与粪便排出。

Related pages on this site

Handling, Storage, and Analytical Verification

Identity and purity are usually assessed by reverse-phase high-performance liquid chromatography coupled to mass spectrometry. Retention time and observed mass are compared against a reference standard run under identical conditions. Impurity profiles reveal deamidation products, oxidized methionine variants, and truncated fragments that arise during synthesis or storage. Peptide mapping through enzymatic digestion confirms the primary sequence, while amino acid analysis offers an independent check on overall composition.

Stability studies examine how temperature, pH, and moisture influence degradation rates over time. In aqueous solution, hydrolysis and deamidation accelerate as pH moves away from mildly acidic conditions. Light exposure and residual metal ions can also trigger oxidation of susceptible residues. Accelerated aging at elevated temperature is used to estimate shelf life, though extrapolation to room temperature carries uncertainty because individual degradation pathways do not always scale predictably.

Lyophilized semaglutide powder is typically held at minus twenty degrees Celsius for long-term storage. At that temperature, solid-state degradation reactions proceed slowly and the peptide remains intact for extended periods. Repeated freeze-thaw cycles are best avoided because they promote aggregation and can shift the proportion of monomeric peptide present. Working aliquots are often prepared so that each portion is thawed only once, and desiccant is placed inside the vial to limit moisture uptake.

Background and Molecular Profile

The sequence incorporates alpha-aminoisobutyric acid at position 8, replacing the alanine found in the natural hormone. This substitution blocks the primary DPP-4 recognition site and contributes most of the enzymatic stability. Albumin binding further protects the peptide and reduces the frequency of administration required to maintain active plasma levels. Because the fatty acid chain increases lipophilicity, the compound is formulated as a solution rather than a simple aqueous buffer. Researchers describe the design as an incremental optimization of earlier GLP-1 analogs rather than a wholly new scaffold.

Reported molecular weight is approximately 4113.6 daltons for the free base, and the peptide is supplied as a lyophilized powder or in buffered liquid form depending on the intended use. It is freely soluble in water when formulated with appropriate excipients, though the unconjugated peptide shows limited stability at neutral pH over long periods. Analytical characterization typically relies on reversed-phase high-performance liquid chromatography and mass spectrometry. Purity specifications for research-grade material commonly exceed ninety-five percent by area. Isotopic and impurity profiles differ between suppliers.

Further detail

Bully: Garrett Height: 6'0 Weight: 199 lb Victim(s): Nicholas and Eric Fighter: Michael Westbrook Height: 6'3 Weight: 212 lb Money earned by Bully: $3,000 Money earned by victim(s): $7,000 Original airing:

== Clinical significance == A common surgical procedure to repair a torn nerve via the epineurium is termed an epineurial repair. Schwannomas often remain completely encapsulated by the epineurium as they grow. Epineurial barriers can be used to limit the formation of neuromas after neurotmesis. The epineurium is an effective barrier against axon growth.

== Treatment == Because cachexia is a complex condition with several potential causes, treatment requires multiple approaches at the same time. The best strategy is to treat the cause of the cachexia, if known. For example, people with cachexia caused by AIDS often improve after starting treatment for AIDS. However, because the exact mechanism of cachexia is unclear, there is no single medication that can effectively treat it. Instead, treatment focuses on a combination of exercise, nutrition, medications like appetite stimulants and androgens like nandrolone decanoate, and psychosocial support.

The Socialist Party of the United States of America (also Socialist Party USA or SPUSA) is a socialist political party in the United States. SPUSA formed in 1973, one year after the Socialist Party of America splintered into three: Social Democrats, USA (legal successor); the Democratic Socialist Organizing Committee (split); and SPUSA. SPUSA describes itself as a multi-tendency socialist party which hopes to win socialism through a "democratic revolution from below". In contrast to the Democratic Socialists of America (DSA), SPUSA advocates for "uncompromising independence" from the Democratic Party. SPUSA describes socialism as "radical democracy", in opposition to "capitalist and authoritarian statist systems". Notable members include David McReynolds, Frank Zeidler, and Dan La Botz. Former members include Ben Burgis.

Baked clay pellets are suitable for hydroponic systems in which all nutrients are carefully controlled in water solution. The clay pellets are inert, pH-neutral, and do not contain any nutrient value. The clay is formed into round pellets and fired in rotary kilns at 1,200 °C (2,190 °F). This causes the clay to expand, like popcorn, and become porous. It is light in weight, and does not compact over time. The shape of an individual pellet can be irregular or uniform depending on brand and manufacturing process. The manufacturers consider expanded clay to be an ecologically sustainable and re-usable growing medium because of its ability to be cleaned and sterilized, typically by washing in solutions of white vinegar, chlorine bleach, or hydrogen peroxide (H2O2), and rinsing completely. Another view is that clay pebbles are best not re-used even when they are cleaned, due to root growth that may enter the medium. Breaking open a clay pebble after use can reveal this growth.

Sources: en.wikipedia.org

Supporting material

== Function == Peptide deformylase removes the formyl group from the N terminus of nascent polypeptides as they are synthesized by the ribosome. The function of peptide deformylase can be described by the following equation, where formyl-L-methionyl peptide and water react under the formation of formate and methionyl peptide:

Aberrant basal cell carcinoma Acanthoma fissuratum (granuloma fissuratum, spectacle frame acanthoma) Acrospiroma (clear cell hidradenoma, dermal duct tumor, hidroacanthoma simplex, nodular hidradenoma, poroma) Actinic keratosis (senile keratosis, solar keratosis) Adenoid squamous cell carcinoma (pseudoglandular squamous cell carcinoma) Aggressive digital papillary adenocarcinoma (digital papillary adenocarcinoma, papillary adenoma) Apocrine gland carcinoma Apocrine nevus Arsenical keratosis Atrophic actinic keratosis Balanitis plasmacellularis (balanoposthitis chronica circumscripta plasmacellularis, balanitis circumscripta plasmacellularis, plasma cell balanitis, plasma cell vulvitis, vulvitis circumscripta plasmacellularis, Zoon's balanitis, Zoon's erythroplasia, Zoon's vulvitis) Basal cell carcinoma Basaloid follicular hamartoma Basaloid squamous cell carcinoma Birt–Hogg–Dubé syndrome Bowen's disease (squamous cell carcinoma in situ) Brooke–Fordyce syndrome Ceruminoma Cicatricial basal cell carcinoma (morpheaform basal cell carcinoma, morphoeic basal cell carcinoma) Ciliated cyst of the vulva (cutaneous Müllerian cyst, paramesonephric mucinous cyst of the vulva) Clear cell acanthoma (acanthome cellules claires of Degos and Civatte, Degos acanthoma, pale cell acanthoma) Clear cell squamous cell carcinoma (clear cell carcinoma of the skin) Chronic scar keratosis (chronic cicatrix keratosis) Clonal seborrheic keratosis Common seborrheic keratosis (basal cell papilloma, solid seborrheic keratosis) Cowden syndrome (Cowden's disease, multiple hamartoma syndrome) Cutaneous ciliated cyst Cutaneous columnar cyst Cutaneous horn (Cornu cutaneum) Cystic basal cell carcinoma Dermal eccrine cylindroma (cylindroma) Dermatosis papulosa nigra Desmoplastic trichoepithelioma Dilated pore (dilated pore of Winer) Eccrine carcinoma (syringoid carcinoma) Eccrine nevus Epidermal cyst (epidermal inclusion cyst, epidermoid cyst, infundibular cyst, keratin cyst) Epidermal nevus syndrome (Feuerstein and Mims syndrome, Solomon's syndrome) Epidermolytic acanthoma Epithelioma cuniculatum (Ackerman tumor, carcinoma cuniculatum) Eruptive vellus hair cyst Erythroplasia of Queyrat Extramammary Paget's disease Fibroepithelioma Fibroepithelioma of Pinkus Fibrofolliculoma Follicular hybrid cyst (Hybrid cyst) Folliculosebaceous-apocrine hamartoma (follicular-apocrine hamartoma) Folliculosebaceous cystic hamartoma Generalized eruptive keratoacanthoma (generalized eruptive keratoacanthoma of Grzybowski) Giant solitary trichoepithelioma Hidradenoma Hidradenocarcinoma Hidrocystoma (cystadenoma, Moll's gland cyst, sudoriferous cyst) Hydrocarbon keratosis (pitch keratosis, tar keratosis, tar wart) Hyperkeratosis lenticularis perstans (Flegel's disease) Hyperkeratosis of the nipple and areola Hyperkeratotic actinic keratosis Ichthyosis hystrix (ichthyosis hystrix gravior type Lambert, porcupine man, systematized verrucous nevus) Ichthyosis hystrix of Curth–Macklin Infiltrative basal cell carcinoma Inflammatory linear verrucous epidermal nevus Inverted follicular keratosis Irritated seborrheic keratosis (basosquamous cell acanthoma, inflamed seborrheic keratosis) Isthmicoma (infundibuloma, tumor of the follicular infundibulum) Juvenile myelomonocytic leukemia Keratin implantation cyst Keratoacanthoma Keratoacanthoma centrifugum marginatum Large cell acanthoma Lichenoid actinic keratosis Lichenoid keratosis (benign lichenoid keratosis, lichen planus-like keratosis, solitary lichen planus, solitary lichenoid keratosis) Linear verrucous epidermal nevus (linear epidermal nevus, verrucous epidermal nevus) Malignant acrospiroma (spiradenocarcinoma) Malignant mixed tumor (malignant chondroid syringoma) Malignant trichilemmal cyst Mantleoma Marjolin's ulcer Melanoacanthoma (pigmented seborrheic keratosis) Merkel cell carcinoma (cutaneous apudoma, primary neuroendocrine carcinoma of the skin, primary small cell carcinoma of the skin, trabecular carcinoma of the skin) Microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) Micronodular basal cell carcinoma Milia en plaque Milium Mixed tumor (chondroid syringoma) Mucinous carcinoma Mucinous nevus (nevus mucinosus) Muir–Torre syndrome Multiple familial trichoepithelioma (Brooke–Spiegler syndrome, epithelioma adenoides cysticum) Multiple keratoacanthomas (Ferguson–Smith syndrome, Ferguson-Smith type of multiple self-healing keratoacanthomas, multiple keratoacanthomas of the Ferguson–Smith type) Multiple minute digitate hyperkeratosis (digitate keratoses, disseminated spiked hyperkeratosis, familial disseminated piliform hyperkeratosis, minute aggregate keratosis) Nevoid basal cell carcinoma syndrome (basal cell nevus syndrome, Gorlin syndrome, Gorlin–Goltz syndrome) Nevus comedonicus (comedo nevus) Nevus comedonicus syndrome Nevus sebaceous (nevus sebaceous of Jadassohn, organoid nevus) Nevus unius lateris Nodular basal cell carcinoma (classic basal cell carcinoma) Paget's disease of the breast Papillary eccrine adenoma (tubular apocrine adenoma) Papillary hidradenoma (hidradenoma papilliferum) Papillomatosis cutis carcinoides (Gottron's carcinoid papillomatosis, papillomatosis cutis carcinoides of Gottron–Eisenlohr) Patch blue nevus (acquired dermal melanocytosis, dermal melanocyte hamartoma) Perifollicular fibroma Phakomatosis pigmentokeratotica Pigmented actinic keratosis Pigmented basal cell carcinoma Pigmented hairy epidermal nevus syndrome Pilar sheath acanthoma Pilonidal sinus (Barber's interdigital pilonidal sinus, pilonidal cyst, pilonidal disease) Porocarcinoma (malignant poroma, eccrine porocarcinoma) Polypoid basal cell carcinoma Pore-like basal cell carcinoma Primary cutaneous adenoid cystic carcinoma Proliferating epidermoid cyst (proliferating epithelial cyst) Proliferating trichilemmal cyst (pilar tumor, proliferating follicular cystic neoplasm, proliferating pilar tumor, proliferating trichilemmal tumor) Pseudocyst of the auricle (auricular endochondrial pseudocyst, cystic chondromalacia, endochondral pseudocyst, intracartilaginous cyst) Pseudoepitheliomatous keratotic and micaceous balanitis PUVA keratosis Rasmussen syndrome Reactional keratosis Reticulated seborrheic keratosis (adenoid seborrheic keratosis) Rodent ulcer (Jacobi ulcer) Schimmelpenning syndrome (Schimmelpenning–Feuerstein–Mims syndrome) Sebaceoma (sebaceous epithelioma) Sebaceous adenoma Sebaceous carcinoma Sebaceous hyperplasia Sebaceous nevus syndrome Seboacanthoma Seborrheic keratosis (seborrheic verruca, senile wart) Seborrheic keratosis with squamous atypia Signet-ring cell squamous cell carcinoma Solitary keratoacanthoma (subungual keratoacanthoma) Solitary trichoepithelioma Spindle cell squamous cell carcinoma (spindle cell carcinoma) Spiradenoma Squamous cell carcinoma Steatocystoma multiplex (epidermal polycystic disease, sebocystomatosis) Steatocystoma simplex (simple sebaceous duct cyst, solitary steatocystoma) Stucco keratosis (digitate seborrheic keratosis, hyperkeratotic seborrheic keratosis, keratosis alba, serrated seborrheic keratosis, verrucous seborrheic keratosis) Superficial basal cell carcinoma (superficial multicentric basal cell carcinoma) Syringadenoma papilliferum (syringocystadenoma papilliferum) Syringofibroadenoma (acrosyringeal nevus of Weedon and Lewis) Syringoma Systematized epidermal nevus Thermal keratosis Trichilemmal carcinoma Trichilemmal cyst (isthmus-catagen cyst, pilar cyst) Trichilemmoma Trichoadenoma (trichoadenoma of Nikolowski) Trichoblastoma Trichoblastic fibroma Trichodiscoma Trichofolliculoma Unilateral palmoplantar verrucous nevus Urethral caruncle Verrucous carcinoma Verrucous cyst (cystic papilloma) Viral keratosis Warty dyskeratoma (isolated dyskeratosis follicularis) Waxy keratosis of childhood (kerinokeratosis papulosa) Zoon's vulvitis Zosteriform speckled lentiginous nevus

=== Size, race, and ethnicity === Alleged differences in races have led to the creation of sexual myths. There is no scientific background to support the alleged "oversized" penis in black people. There is no indication that penis size differs between ethnicities. According to urologist Aaron Spitz, many websites and studies promoting variation of penis size between races use unscientific methods of collecting information and often ignore contradictory evidence. He concludes that "when you really take a good look at the naked data, there's not a whole lot there [showing racial variation in penis size]." A 2024 meta-analysis of 34,060 Chinese men found that while flaccid penis length was shorter on average than the global reference population, erect length showed no statistically significant difference. The study found that Chinese men had a higher average increase from flaccid to erect state (67%) compared to the global average (43%), meaning a greater proportion fell into the category colloquially known as "growers" rather than "showers." The authors noted this has implications for older cross-population studies, many of which relied on flaccid rather than erect measurements: populations with more "growers" would appear smaller in flaccid-based datasets even when erect dimensions are comparable. While some meta-analyses have identified modest average differences across geographic regions, the variation in penis size within any racial or ethnic group vastly exceeds the differences between groups.

== Medical uses == Isotretinoin is used primarily for persistent cystic acne. Many dermatologists also support its use for treatment of lesser degrees of acne that prove resistant to other treatments, or that produce scarring or psychological distress. Isotretinoin is not indicated for the treatment of prepubertal acne and is not recommended in children less than 12 years of age. It is also somewhat effective for hidradenitis suppurativa and some cases of severe rosacea. It can also be used to help treat harlequin ichthyosis, lamellar ichthyosis and is used in xeroderma pigmentosum cases to relieve keratoses. Isotretinoin has been used to treat the extremely rare condition fibrodysplasia ossificans progressiva. It is also used for the treatment of pediatric neuroblastoma in Japan, but data for its efficacy is not conclusive and it has not been approved in other countries. Isotretinoin therapy has furthermore proven effective against genital warts in experimental use but is rarely used for this indication as there are more effective treatments. Isotretinoin may represent an efficacious and safe alternative systemic form of therapy for recalcitrant condylomata acuminata (RCA) of the cervix. In most countries, this therapy is currently unapproved and only used if other therapies fail.

== Neoplasms of uncertain behavior (235–238) == 235 Neoplasm of uncertain behavior of digestive and respiratory systems 236 Neoplasm of uncertain behavior of genitourinary organs 237 Neoplasm of uncertain behavior of endocrine glands and nervous system 237.0 Pituitary gland and craniopharyngeal duct Pituitary adenoma 237.7 Neurofibromatosis 238 Neoplasm of uncertain behavior of other and unspecified sites and tissues 238.4 Polycythemia vera

Sources: en.wikipedia.org

Frequently asked questions

How does semaglutide differ from native GLP-1?

Native GLP-1 is a short-lived peptide cleared within one to two minutes by dipeptidyl peptidase-4 and related enzymes. Semaglutide keeps the receptor-binding backbone but adds substitutions and a lipid chain. These changes block the main cleavage site and allow reversible albumin binding, extending the half-life to roughly 165 hours.

Why does albumin binding matter for duration of action?

Albumin is the most abundant protein in plasma and carries molecules that bear fatty-acid chains. Binding shields the peptide from renal filtration and from peptidases, keeping a circulating reservoir. Slow release from this reservoir produces sustained receptor occupancy and supports infrequent dosing.

Is the insulin-releasing effect dependent on blood glucose?

The insulinotropic effect is glucose-dependent, meaning secretion increases mainly when glucose is elevated. This property is often described as lowering the chance of hypoglycaemia when the compound is used alone. Other glucose-lowering agents used at the same time can still cause low blood glucose.

Is semaglutide a peptide rather than a small molecule?

It is a synthetic peptide of 31 amino acids, built to resemble the natural incretin hormone GLP-1. Because of its size and composition it is handled analytically like other therapeutic peptides, using chromatographic and mass spectrometric methods rather than the techniques typical of small organic drugs.

Network